Nonetheless, this approach has been used to demonstrate that immuno-labelling with anti-Kit and anti-Ano1 antibodies have consistently identified ICC throughout gastric (stomach), small intestine and colon tissue [25,27,28,32,46]. The gene discussed is ANO1; the disease is intrahepatic cholangiocarcinoma.